Cardinal Capital Management Purchases 21,629 Shares of Phibro Animal Health Corporation $PAHC

Key Points

• Cardinal Capital Management increased its stake in Phibro Animal Health Corporation by 28.8% during Q2, acquiring an additional 21,629 shares to own a total of 96,639 shares valued at approximately $2.47 million.
• Phibro Animal Health's CEO, Jack Bendheim, sold 7,022 shares in September, reducing his ownership by 18.31% to 31,338 shares, valued at around $1.26 million following the sale.
• Analysts have mixed opinions on Phibro Animal Health, with a consensus rating of "Reduce" and an average target price of $28.40, while recent earnings reports showed a quarterly earnings per share of $0.57, exceeding expectations.

Cardinal Capital Management lifted its position in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 28.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 96,639 shares of the company's stock after purchasing an additional 21,629 shares during the quarter. Cardinal Capital Management owned about 0.24% of Phibro Animal Health worth $2,468,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in PAHC. Nuveen LLC bought a new position in Phibro Animal Health in the 1st quarter worth about $10,312,000. Invesco Ltd. increased its position in shares of Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company's stock worth $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Axecap Investments LLC bought a new position in shares of Phibro Animal Health in the first quarter worth approximately $3,696,000. Millennium Management LLC increased its holdings in shares of Phibro Animal Health by 74.3% in the 1st quarter. Millennium Management LLC now owns 362,030 shares of the company's stock worth $7,733,000 after buying an additional 154,281 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of Phibro Animal Health by 711.1% in the 1st quarter. Russell Investments Group Ltd. now owns 122,600 shares of the company's stock worth $2,619,000 after buying an additional 107,485 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Phibro Animal Health

In related news, CEO Jack Bendheim sold 7,022 shares of Phibro Animal Health stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $40.26, for a total transaction of $282,705.72. Following the sale, the chief executive officer directly owned 31,338 shares in the company, valued at $1,261,667.88. The trade was a 18.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold 24,622 shares of company stock worth $995,893 in the last 90 days. Insiders own 50.07% of the company's stock.

Wall Street Analyst Weigh In

PAHC has been the topic of a number of research analyst reports. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price target on the stock in a report on Monday, June 16th. Bank of America increased their target price on Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research note on Friday, August 29th. BNP Paribas upgraded Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price objective for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Finally, Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a research report on Thursday, August 28th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Reduce" and an average target price of $28.40.

Phibro Animal Health Trading Down 3.7%

Shares of PAHC opened at $38.40 on Tuesday. The firm's 50-day moving average price is $33.00 and its 200-day moving average price is $26.21. The firm has a market capitalization of $1.56 billion, a price-to-earnings ratio of 32.54, a PEG ratio of 1.18 and a beta of 0.88. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $41.57.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.05. The firm had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. Sell-side analysts anticipate that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health's payout ratio is currently 40.68%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.